| Product Code: ETC9507680 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Carrier Screening Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Carrier Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Carrier Screening Market - Industry Life Cycle |
3.4 Suriname Carrier Screening Market - Porter's Five Forces |
3.5 Suriname Carrier Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Suriname Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Suriname Carrier Screening Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.8 Suriname Carrier Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Suriname Carrier Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Suriname Carrier Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about genetic disorders and the importance of carrier screening in Suriname |
4.2.2 Growing demand for preconception and prenatal genetic testing in the country |
4.2.3 Advancements in technology leading to more accurate and affordable carrier screening tests |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and genetic testing services in remote areas of Suriname |
4.3.2 High costs associated with carrier screening tests may hinder adoption among the population |
4.3.3 Cultural beliefs and stigmas surrounding genetic testing and hereditary conditions |
5 Suriname Carrier Screening Market Trends |
6 Suriname Carrier Screening Market, By Types |
6.1 Suriname Carrier Screening Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Carrier Screening Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Suriname Carrier Screening Market Revenues & Volume, By Molecular Screening Test, 2021- 2031F |
6.1.4 Suriname Carrier Screening Market Revenues & Volume, By Biochemical Screening Test, 2021- 2031F |
6.2 Suriname Carrier Screening Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Carrier Screening Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.3 Suriname Carrier Screening Market Revenues & Volume, By Tay-Sachs, 2021- 2031F |
6.2.4 Suriname Carrier Screening Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.2.5 Suriname Carrier Screening Market Revenues & Volume, By Sickle Cell Disease, 2021- 2031F |
6.2.6 Suriname Carrier Screening Market Revenues & Volume, By Spinal Muscular Atrophy, 2021- 2031F |
6.2.7 Suriname Carrier Screening Market Revenues & Volume, By Other Autosomal Recessive Genetic Disorders, 2021- 2031F |
6.3 Suriname Carrier Screening Market, By Medical Condition |
6.3.1 Overview and Analysis |
6.3.2 Suriname Carrier Screening Market Revenues & Volume, By Pulmonary Conditions, 2021- 2031F |
6.3.3 Suriname Carrier Screening Market Revenues & Volume, By Hematological Conditions, 2021- 2031F |
6.3.4 Suriname Carrier Screening Market Revenues & Volume, By Neurological Conditions, 2021- 2031F |
6.3.5 Suriname Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Suriname Carrier Screening Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Suriname Carrier Screening Market Revenues & Volume, By DNA Sequencing, 2021- 2031F |
6.4.3 Suriname Carrier Screening Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.4.4 Suriname Carrier Screening Market Revenues & Volume, By Microarrays, 2021- 2031F |
6.4.5 Suriname Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Suriname Carrier Screening Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Suriname Carrier Screening Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Suriname Carrier Screening Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.5.4 Suriname Carrier Screening Market Revenues & Volume, By Physician Offices and Clinics, 2021- 2031F |
6.5.5 Suriname Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Carrier Screening Market Import-Export Trade Statistics |
7.1 Suriname Carrier Screening Market Export to Major Countries |
7.2 Suriname Carrier Screening Market Imports from Major Countries |
8 Suriname Carrier Screening Market Key Performance Indicators |
8.1 Percentage increase in the number of genetic counseling sessions conducted annually |
8.2 Adoption rate of carrier screening tests among high-risk populations in Suriname |
8.3 Average turnaround time for carrier screening test results to be delivered to patients |
9 Suriname Carrier Screening Market - Opportunity Assessment |
9.1 Suriname Carrier Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Suriname Carrier Screening Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Suriname Carrier Screening Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.4 Suriname Carrier Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Suriname Carrier Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Suriname Carrier Screening Market - Competitive Landscape |
10.1 Suriname Carrier Screening Market Revenue Share, By Companies, 2024 |
10.2 Suriname Carrier Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here